Cargando…

Evaluation of the detection of Toll-like receptors (TLRs) in cancer development and progression in patients with colorectal cancer

BACKGROUND: Toll-like receptors (TLRs) play essential role in innate and acquired immunity, are expressed in various cell types, and are associated with altered susceptibility to many diseases, and cancers. The aim of this study was to investigate TLR2 (-196 to-174del), TLR4 (Asp299Gly and Thr399Ile...

Descripción completa

Detalles Bibliográficos
Autores principales:	Messaritakis, Ippokratis, Stogiannitsi, Maria, Koulouridi, Asimina, Sfakianaki, Maria, Voutsina, Alexandra, Sotiriou, Afroditi, Athanasakis, Elias, Xynos, Evangelos, Mavroudis, Dimitris, Tzardi, Maria, Souglakos, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993256/ https://www.ncbi.nlm.nih.gov/pubmed/29883450 http://dx.doi.org/10.1371/journal.pone.0197327

Ejemplares similares

The Role of Vitamin D Receptor Gene Polymorphisms in Colorectal Cancer Risk
por: Messaritakis, Ippokratis, et al.
Publicado: (2020)

Investigation of Microbial Translocation, TLR and VDR Gene Polymorphisms, and Recurrence Risk in Stage III Colorectal Cancer Patients
por: Messaritakis, Ippokratis, et al.
Publicado: (2022)

Prognostic Value of KRAS Mutations in Colorectal Cancer Patients
por: Koulouridi, Asimina, et al.
Publicado: (2022)

Detection of Circulating Tumor Cells and Microbial DNA Fragments in Stage III Colorectal Cancer Patients under Three versus Six Months of Adjuvant Treatment
por: Koulouridi, Asimina, et al.
Publicado: (2021)

Resectable Colorectal Cancer: Current Perceptions on the Correlation of Recurrence Risk, Microbiota and Detection of Genetic Mutations in Liquid Biopsies
por: Koulouris, Andreas, et al.
Publicado: (2021)

The Prognostic Value of the Detection of Microbial Translocation in the Blood of Colorectal Cancer Patients
por: Messaritakis, Ippokratis, et al.
Publicado: (2020)

Evaluation of the Role of Circulating Tumor Cells and Microsatellite Instability Status in Predicting Outcome of Advanced CRC Patients
por: Messaritakis, Ippokratis, et al.
Publicado: (2020)

BRAFV600E Mutation Analysis in Patients with Metastatic Colorectal Cancer (mCRC) in Daily Clinical Practice: Correlations with Clinical Characteristics, and Its Impact on Patients’ Outcome
por: Saridaki, Zacharenia, et al.
Publicado: (2013)

PKM2 Expression as Biomarker for Resistance to Oxaliplatin-Based Chemotherapy in Colorectal Cancer
por: Sfakianaki, Maria, et al.
Publicado: (2020)

Immunotherapy in Solid Tumors and Gut Microbiota: The Correlation—A Special Reference to Colorectal Cancer
por: Koulouridi, Asimina, et al.
Publicado: (2020)

Cancer-Associated Fibroblasts: The Origin, Biological Characteristics and Role in Cancer—A Glance on Colorectal Cancer
por: Fotsitzoudis, Charalampos, et al.
Publicado: (2022)

Loss of LKB1 Protein Expression Correlates with Increased Risk of Recurrence and Death in Patients with Resected, Stage II or III Colon Cancer
por: Sfakianaki, Maria, et al.
Publicado: (2019)

Unraveling the Role of Molecular Profiling in Predicting Treatment Response in Stage III Colorectal Cancer Patients: Insights from the IDEA International Study
por: Messaritakis, Ippokratis, et al.
Publicado: (2023)

Evaluation of Microsatellite Instability Molecular Analysis versus Immuno-Histochemical Interpretation in Malignant Neoplasms with Different Localizations
por: Sfakianaki, Maria, et al.
Publicado: (2023)

Impact of KRAS, BRAF, PIK3CA Mutations, PTEN, AREG, EREG Expression and Skin Rash in ≥2(nd) Line Cetuximab-Based Therapy of Colorectal Cancer Patients
por: Saridaki, Zacharenia, et al.
Publicado: (2011)

Brain and bone marrow metastases from rectal cancer
por: Thomopoulou, Konstantina, et al.
Publicado: (2020)

Correlation of PKM2 and CD44 Protein Expression with Poor Prognosis in Platinum-Treated Epithelial Ovarian Cancer: A Retrospective Study
por: Papadaki, Chara, et al.
Publicado: (2020)

KRAS Genotypic Changes of Circulating Tumor Cells during Treatment of Patients with Metastatic Colorectal Cancer
por: Kalikaki, Aristea, et al.
Publicado: (2014)

Immunotherapy in Metastatic Colorectal Cancer: Could the Latest Developments Hold the Key to Improving Patient Survival?
por: Damilakis, Emmanouil, et al.
Publicado: (2020)

Intestinal Microbiota in Colorectal Cancer Surgery
por: Koliarakis, Ioannis, et al.
Publicado: (2020)

Assessment of the Efficacy and Clinical Utility of Different Circulating Tumor Cell (CTC) Detection Assays in Patients with Chemotherapy-Naïve Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
por: Papadaki, Maria A., et al.
Publicado: (2021)

Oral Bacteria and Intestinal Dysbiosis in Colorectal Cancer
por: Koliarakis, Ioannis, et al.
Publicado: (2019)

Evaluation of Febrile Neutropenia in Hospitalized Patients with Neoplasia Undergoing Chemotherapy
por: Bachlitzanaki, Maria, et al.
Publicado: (2023)

The role of toll-like receptors (TLRs) in pan-cancer
por: Huang, Runzhi, et al.
Publicado: (2022)

A Case Presentation of a Patient with Microsatellite Instability and BRAF Mutant Metastatic Colon Cancer and Bibliography Update
por: Thomopoulou, K., et al.
Publicado: (2019)

Detection of KRAS Exon 2 Mutations in Circulating Tumor Cells Isolated by the ISET System from Patients with RAS Wild Type Metastatic Colorectal Cancer()
por: Matikas, Alexios, et al.
Publicado: (2017)

PKM2 as a biomarker for chemosensitivity to front-line platinum-based chemotherapy in patients with metastatic non-small-cell lung cancer
por: Papadaki, C, et al.
Publicado: (2014)

Predictive Value of BRCA1, ERCC1, ATP7B, PKM2, TOPOI, TOPΟ-IIA, TOPOIIB and C-MYC Genes in Patients with Small Cell Lung Cancer (SCLC) Who Received First Line Therapy with Cisplatin and Etoposide
por: Karachaliou, Niki, et al.
Publicado: (2013)

Comprehensive Bioinformatics Analysis of Toll-Like Receptors (TLRs) in Pan-Cancer
por: Ping, Wei, et al.
Publicado: (2022)

Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy
por: Chakraborty, Samik, et al.
Publicado: (2023)

Toll-Like Receptors (TLRs): Structure, Functions, Signaling, and Role of Their Polymorphisms in Colorectal Cancer Susceptibility
por: Sameer, Aga Syed, et al.
Publicado: (2021)

The expression and function of toll-like receptors (TLRs) in ovarian cancer cell lines
por: Lee, Shin-Wha, et al.
Publicado: (2015)

The Role of Toll-like Receptors (TLRs) Mediated Inflammation in Pancreatic Cancer Pathophysiology
por: Orlacchio, Arturo, et al.
Publicado: (2021)

Toll-Like Receptors (TLRs): The Role in Tumor Progression
por: Shcheblyakov, D.V., et al.
Publicado: (2010)

Toll like Receptors (TLRs) expression in HIV children
por: Madeshwaran, M, et al.
Publicado: (2014)

Synucleinopathies Take Their Toll: Are TLRs a Way to Go?
por: Mazzotta, Gabriella M., et al.
Publicado: (2023)

The expression and prognostic value of toll-like receptors (TLRs) in pancreatic cancer patients treated with neoadjuvant therapy
por: Nurmi, Anna Maria, et al.
Publicado: (2022)

The expression of Toll-Like Receptors (TLRs) in testicular cancer: A case control study
por: Shapouri, Farnaz, et al.
Publicado: (2013)

Adaptive Evolution of Toll-Like Receptors (TLRs) in the Family Suidae
por: Darfour-Oduro, Kwame A., et al.
Publicado: (2015)

TTF-1- and/or CD56-positive Circulating Tumor Cells in patients with small cell lung cancer (SCLC)
por: Messaritakis, Ippokratis, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dj1897hipt6u3l9utn57mj2qdh